Cyfuse Biomedical KK (TSE:4892) Total Stockholders Equity : 円3,203.47 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Total Stockholders Equity?

Cyfuse Biomedical KK's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円3,203.47 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cyfuse Biomedical KK's Book Value per Share for the quarter that ended in Dec. 2023 was 円405.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cyfuse Biomedical KK's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.29.

Cyfuse Biomedical KK Total Stockholders Equity Historical Data

The historical data trend for Cyfuse Biomedical KK's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Total Stockholders Equity Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

1,549.46

1,900.12

3,769.80

3,203.47

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial				3,769.80	3,605.53	3,410.64	3,241.16	3,203.47

Cyfuse Biomedical KK (TSE:4892) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cyfuse Biomedical KK's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3203.469	-	0)	/	7.8943
	=	405.80

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cyfuse Biomedical KK's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(568	+	345)	/	3203.469
	=	0.29

Cyfuse Biomedical KK Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines